Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.
2.

Effect of enalapril on hemorheology in hypertensive patients with renal disease.

Shand BI, Bailey RR, Lynn KL, Robson RA.

Clin Exp Hypertens. 1995 May;17(4):689-700.

PMID:
7795581
3.

Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.

Kearney-Schwartz A, Virion JM, Stoltz JF, Drouin P, Zannad F.

Fundam Clin Pharmacol. 2007 Aug;21(4):387-96.

PMID:
17635177
4.

The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension.

Donmez G, Derici U, Erbas D, Arinsoy T, Onk A, Sindel S, Hasanoglu E.

Jpn J Physiol. 2002 Oct;52(5):435-40.

PMID:
12533248
6.

Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.

Jilma B, Li-Saw-Hee FL, Wagner OF, Beevers DG, Lip GY.

Clin Sci (Lond). 2002 Aug;103(2):131-6.

PMID:
12149103
7.

Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan.

Nawarskas JJ, Townsend RR, Cirigliano MD, Spinler SA.

Am J Hypertens. 1999 Aug;12(8 Pt 1):784-9.

PMID:
10480471
8.

Effect of losartan on haematology and haemorheology in elderly patients with essential hypertension: a pilot study.

Shand BI, Gilchrist NL, Nicholls MG, Bailey RR.

J Hum Hypertens. 1995 Apr;9(4):233-5.

PMID:
7595904
9.
10.

ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.

Fogari R, Zoppi A, Lazzari P, Preti P, Mugellini A, Corradi L, Lusardi P.

J Cardiovasc Pharmacol. 1998 Oct;32(4):616-20.

PMID:
9781930
11.

Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients.

Azizi M, Linhart A, Alexander J, Goldberg A, Menten J, Sweet C, Ménard J.

J Hypertens. 2000 Aug;18(8):1139-47.

PMID:
10954007
13.
14.
16.

T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans.

Petrov VV, Fagard RH, Lijnen PJ.

J Cardiovasc Pharmacol. 2001 Oct;38(4):578-83.

PMID:
11588528
17.

The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group..

Clin Ther. 2008 Mar;30(3):482-98. doi: 10.1016/j.clinthera.2008.03.006.

PMID:
18405787
18.
19.

CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.

Spinar J, Vítovec J, Soucek M, Dusek L, Pavlík T; CORD Invesigators..

Vnitr Lek. 2009 May;55(5):481-8.

PMID:
19514614
20.

Long-term treatment with enalapril or losartan does not show antiproliferative effects in peripheral blood mononuclear cells.

Petrov VV, Fagard RH, Lijnen PJ.

Methods Find Exp Clin Pharmacol. 2001 Apr;23(3):149-52.

PMID:
11523315
Items per page

Supplemental Content

Support Center